Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316983914> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2316983914 endingPage "178" @default.
- W2316983914 startingPage "173" @default.
- W2316983914 abstract "Based on preclinical studies demonstrating synergy between gallium and hydroxyurea, we evaluated the efficacy and toxicity of continuous intravenous gallium nitrate in combination with oral hydroxyurea in patients with refractory non-Hodgkin's lymphoma. Fourteen patients, median age 64 years (range 53-89), with stage III or IV low- or intermediate-grade lymphoma were treated with gallium nitrate and hydroxyurea in combination for 7 days at four different dose levels: (a) gallium nitrate, 200 mg/m2/day; hydroxyurea, 500 mg/day; (b) gallium nitrate, 250 mg/m2/day; hydroxyurea, 1,000 mg/day; (c) gallium nitrate, 300 mg/m2/day; hydroxyurea, 1,000 mg/day; and (d) gallium nitrate, 350 mg/m2/day, hydroxyurea, 1,000 mg/day. All patients had progressive disease and had been heavily pretreated. Six of 14 patients had objective tumor regression following treatment (one complete response, one near-complete response, and four partial responses) with a median duration of response of 7 weeks (range 3-38 weeks). An additional four patients had minor responses. Responses occurred at all dose levels and in both low- and intermediate-grade histologic subtypes. The predominant toxicities encountered were anemia and reversible nephrotoxicity. Combination gallium nitrate and hydroxyurea has significant activity in lymphoma and is well tolerated even by elderly patients. Because of the lack of cross-resistance to other drugs and the potential synergistic antineoplastic activity, gallium nitrate and hydroxyurea should be further evaluated in combination with other chemotherapeutic agents." @default.
- W2316983914 created "2016-06-24" @default.
- W2316983914 creator A5025246228 @default.
- W2316983914 creator A5057163122 @default.
- W2316983914 creator A5075046330 @default.
- W2316983914 creator A5089941984 @default.
- W2316983914 date "1997-04-01" @default.
- W2316983914 modified "2023-10-09" @default.
- W2316983914 title "Evaluation of Continuous-Infusion Gallium Nitrate and Hydroxyurea in Combination for the Treatment of Refractory Non-Hodgkin's Lymphoma" @default.
- W2316983914 cites W1510306624 @default.
- W2316983914 cites W1765633821 @default.
- W2316983914 cites W1964812457 @default.
- W2316983914 cites W1972419942 @default.
- W2316983914 cites W1976770725 @default.
- W2316983914 cites W1981325700 @default.
- W2316983914 cites W2016835142 @default.
- W2316983914 cites W2042425026 @default.
- W2316983914 cites W2061225636 @default.
- W2316983914 doi "https://doi.org/10.1097/00000421-199704000-00015" @default.
- W2316983914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9124195" @default.
- W2316983914 hasPublicationYear "1997" @default.
- W2316983914 type Work @default.
- W2316983914 sameAs 2316983914 @default.
- W2316983914 citedByCount "33" @default.
- W2316983914 countsByYear W23169839142012 @default.
- W2316983914 countsByYear W23169839142013 @default.
- W2316983914 countsByYear W23169839142015 @default.
- W2316983914 countsByYear W23169839142019 @default.
- W2316983914 crossrefType "journal-article" @default.
- W2316983914 hasAuthorship W2316983914A5025246228 @default.
- W2316983914 hasAuthorship W2316983914A5057163122 @default.
- W2316983914 hasAuthorship W2316983914A5075046330 @default.
- W2316983914 hasAuthorship W2316983914A5089941984 @default.
- W2316983914 hasConcept C126322002 @default.
- W2316983914 hasConcept C142424586 @default.
- W2316983914 hasConcept C178790620 @default.
- W2316983914 hasConcept C185592680 @default.
- W2316983914 hasConcept C18903297 @default.
- W2316983914 hasConcept C2776384668 @default.
- W2316983914 hasConcept C2776694085 @default.
- W2316983914 hasConcept C2779338263 @default.
- W2316983914 hasConcept C29730261 @default.
- W2316983914 hasConcept C550372918 @default.
- W2316983914 hasConcept C71924100 @default.
- W2316983914 hasConcept C86803240 @default.
- W2316983914 hasConcept C87355193 @default.
- W2316983914 hasConcept C90924648 @default.
- W2316983914 hasConceptScore W2316983914C126322002 @default.
- W2316983914 hasConceptScore W2316983914C142424586 @default.
- W2316983914 hasConceptScore W2316983914C178790620 @default.
- W2316983914 hasConceptScore W2316983914C185592680 @default.
- W2316983914 hasConceptScore W2316983914C18903297 @default.
- W2316983914 hasConceptScore W2316983914C2776384668 @default.
- W2316983914 hasConceptScore W2316983914C2776694085 @default.
- W2316983914 hasConceptScore W2316983914C2779338263 @default.
- W2316983914 hasConceptScore W2316983914C29730261 @default.
- W2316983914 hasConceptScore W2316983914C550372918 @default.
- W2316983914 hasConceptScore W2316983914C71924100 @default.
- W2316983914 hasConceptScore W2316983914C86803240 @default.
- W2316983914 hasConceptScore W2316983914C87355193 @default.
- W2316983914 hasConceptScore W2316983914C90924648 @default.
- W2316983914 hasIssue "2" @default.
- W2316983914 hasLocation W23169839141 @default.
- W2316983914 hasLocation W23169839142 @default.
- W2316983914 hasOpenAccess W2316983914 @default.
- W2316983914 hasPrimaryLocation W23169839141 @default.
- W2316983914 hasRelatedWork W141156546 @default.
- W2316983914 hasRelatedWork W2019641145 @default.
- W2316983914 hasRelatedWork W2050819398 @default.
- W2316983914 hasRelatedWork W2315509634 @default.
- W2316983914 hasRelatedWork W2344008110 @default.
- W2316983914 hasRelatedWork W2376931664 @default.
- W2316983914 hasRelatedWork W2378084453 @default.
- W2316983914 hasRelatedWork W2949859754 @default.
- W2316983914 hasRelatedWork W2950238895 @default.
- W2316983914 hasRelatedWork W4230215600 @default.
- W2316983914 hasVolume "20" @default.
- W2316983914 isParatext "false" @default.
- W2316983914 isRetracted "false" @default.
- W2316983914 magId "2316983914" @default.
- W2316983914 workType "article" @default.